Grifols and Selagine collaborate to produce 'game-changing' dry eye disease treatment 14-Mar-2023 By Liza Laws Grifols has entered into a collaboration and licensing agreement with Selagine to develop immunoglobulin (Ig) eye drops to treat dry eye disease.
EyeBio building assets to treat macular edema and degeneration 07-Mar-2023 By Jane Byrne Ophthalmology biotechnology company EyeBio shared details on its first asset in a diversified pipeline aimed at addressing serious eye diseases.
Celanese partners with Johns Hopkins on eye drug delivery 20-Feb-2023 By Ben Hargreaves The partners will collaborate on a study of sustained drug delivery to the suprachoroidal space in the eye.